WO2001077124A3 - Haplotypes du gene apoa4 - Google Patents

Haplotypes du gene apoa4 Download PDF

Info

Publication number
WO2001077124A3
WO2001077124A3 PCT/US2001/010670 US0110670W WO0177124A3 WO 2001077124 A3 WO2001077124 A3 WO 2001077124A3 US 0110670 W US0110670 W US 0110670W WO 0177124 A3 WO0177124 A3 WO 0177124A3
Authority
WO
WIPO (PCT)
Prior art keywords
apoa4
gene
haplotypes
disclosed
apoa4 gene
Prior art date
Application number
PCT/US2001/010670
Other languages
English (en)
Other versions
WO2001077124A2 (fr
Inventor
Steven C Bentivegna
Julie Y Choi
Stefanie E Kliem
Beena Koshy
Original Assignee
Genaissance Pharmaceuticals
Steven C Bentivegna
Julie Y Choi
Stefanie E Kliem
Beena Koshy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Steven C Bentivegna, Julie Y Choi, Stefanie E Kliem, Beena Koshy filed Critical Genaissance Pharmaceuticals
Priority to AU2001251245A priority Critical patent/AU2001251245A1/en
Publication of WO2001077124A2 publication Critical patent/WO2001077124A2/fr
Publication of WO2001077124A3 publication Critical patent/WO2001077124A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des nouveaux polymorphismes de nucléotides simple dans le gène A-IV (APOA4) de l'apolipoprotéine chez l'homme. En outre, l'invention concerne divers génotypes, divers haplotypes et diverses paires d'haplotypes du gène APOA4 existant dans la population. L'invention concerne également des compositions et des procédés permettant d'haplotyper et/ou de génotyper le gène APOA4 dans un individu. L'invention concerne également des polynucléotides renfermant un ou plusieurs polymorphismes du gène APOA4.
PCT/US2001/010670 2000-04-05 2001-04-03 Haplotypes du gene apoa4 WO2001077124A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001251245A AU2001251245A1 (en) 2000-04-05 2001-04-03 Haplotypes of the apoa4 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19436200P 2000-04-05 2000-04-05
US60/194,362 2000-04-05

Publications (2)

Publication Number Publication Date
WO2001077124A2 WO2001077124A2 (fr) 2001-10-18
WO2001077124A3 true WO2001077124A3 (fr) 2002-10-03

Family

ID=22717288

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/010670 WO2001077124A2 (fr) 2000-04-05 2001-04-03 Haplotypes du gene apoa4

Country Status (2)

Country Link
AU (1) AU2001251245A1 (fr)
WO (1) WO2001077124A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3979099A (en) 1998-05-11 1999-11-29 Philadelphia Health & Education Corporation (mct-1), a human oncogene
US20030113808A1 (en) * 2001-12-13 2003-06-19 George Jackowski Apolipoprotein biopolymer markers predictive of alzheimers disease
US20040005566A1 (en) * 2002-07-02 2004-01-08 Genelink, Inc. Kits and methods for assessing cardiovascular health
FR2893136A1 (fr) * 2005-11-10 2007-05-11 Sanofi Aventis Sa Procedes de diagnostic de maladies hepatiques et de criblage de molecules pour le traitement de ces maladies
MX342020B (es) * 2011-01-19 2016-09-08 Univ Cincinnati Apolipoproteina a-iv como un peptido antidiabetico.

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
CENARRO ET AL.: "Polymorphisms in the human apolipoproteins aiv gene detected by PCR and SSCP/heteroduplex analysis", MOLECULAR AND CELLULAR PROBES, vol. 12, 1998, pages 117 - 120, XP002949655 *
DATABASE GENBANK [online] 11 April 1996 (1996-04-11), XP002949654, Database accession no. J02758 *
DEEB ET AL.: "Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity", HUMAN MUTATION, vol. 8, 1996, pages 319 - 325, XP002949659 *
ELSHOURBAGY ET AL.: "Structure and expression of the human apolipoprotein A-IV gene", J. OF BIOL. CHEM., vol. 262, no. 17, 15 June 1987 (1987-06-15), pages 7973 - 7981, XP002949653 *
LOHSE ET AL.: "Genetic polymorphism of human plasma apolipoprotein A-IV is due to nucleotide substitutions in the apolipoprotein A-IV gene", J. OF BIOL. CHEMISTRY, vol. 265, no. 17, 15 June 1990 (1990-06-15), pages 10061 - 10064, XP002949658 *
TENKANEN ET AL.: "A novel polymorphisms of apolipoprotein A-IV is the results of an asparagine to serine substitution at residue 127", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1138, 1992, pages 27 - 33, XP002949657 *
VON ECKARDSTEIN ET AL.: "Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-1 containing lipoproteins in a normal population", AMERICAN J. HUMAN GENETICS, vol. 50, 1992, pages 1115 - 1128, XP002949656 *

Also Published As

Publication number Publication date
AU2001251245A1 (en) 2001-10-23
WO2001077124A2 (fr) 2001-10-18

Similar Documents

Publication Publication Date Title
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2001077124A3 (fr) Haplotypes du gene apoa4
WO2001079229A3 (fr) Haplotypes du gene cxcr4
WO2001079230A3 (fr) Haplotypes du gene ugt1a1
WO2001090123A3 (fr) Haplotypes du gene agtrl1
WO2001079228A3 (fr) Haplotypes du gene f12
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2001077129A3 (fr) Haplotypes du gene apoc1
WO2001079218A3 (fr) Haplotypes du gene calm1
WO2001079224A3 (fr) Haplotypes du gene cyp8b1
WO2001079219A3 (fr) Haplotypes du gene ache
WO2001058914A3 (fr) Haplotypes du gene de l'interleukine 15
WO2001079240A3 (fr) Haplotypes du gene rangap1
WO2001077127A3 (fr) Haplotypes du gene apoc4
WO2001077130A3 (fr) Haplotypes du gene apoa2
WO2001079232A3 (fr) Haplotypes du gene mpl
WO2001072966A3 (fr) Haplotypes du gene pltp
WO2001072965A3 (fr) Haplotypes du gene fkbp8
WO2001079974A3 (fr) Haplotypes du gene f9
WO2001090127A3 (fr) Haplotypes du gene de hoxd3
WO2001079238A3 (fr) Haplotypes du gene mmp3
WO2001079237A3 (fr) Haplotypes du gene galr1
WO2001077131A3 (fr) Haplotypes du gene bglap
WO2001075065A3 (fr) Haplotypes du gene gp1ba

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP